Browsing by Author "Kalayoğlu Beşışık, Sevgi"
Now showing items 1-10 of 10
-
Clinical relevance of minor histocompatibility antigens
Savran Oğuz, Fatma; Kekik Çınar, Çiğdem; Oğuz, Seda B.; Sargın, Deniz; Kalayoğlu Beşışık, Sevgi (Pergamon-Elsevier Science, 2019)Objective: The minor histocompatibility antigens (MiHA) are epitopes composed of polymorphic essential peptides evoking alloimmune responses limited to a variety of human leukocyte antigen (HLA) alleles. These peptides are ... -
HLA-A allele mismatch (7/8 or 9/10) is the second best option after 8/8 or 10/10 matched unrelated donors: An analysis on results from Turkish centers
Beksaç, Meral; Savran Oğuz, Fatma; Topçuoğlu, Pervin; Karasu, Gülsun; Arat, Mutlu; Aksoylar, Serap; Kansoy, Savaş; Kalayoğlu Beşışık, Sevgi; Küpesiz, Alphan; Hazar, Volkan; Altuntaş, Fevzi; Ünal, Ali; Gülbaş, Zafer; Sargın, Fatma Deniz; İlhan, Osman; Gürman, Günhan; Yeşilipek, Akif (Nature Publishing Group, 2015)Introduction: Hematopoietic stem cell transplantation (HSCT) from an unrelated donor has been established as an effective treatment option for patients with hematological diseases who lack a human leukocyte antigen ... -
Immunoglobulin V(D) J recombination, protein ubiquitination, cell adhesion and sonic hedgehog gene variants are detected among familial multiple myeloma subjects following whole exome sequencing
Akkuş, Erman; Tunçali, Timur; Aydın, Yıldız; Kalayoğlu Beşışık, Sevgi; Gürkan, Emel; Ratip, Siret; Salihoğlu, Ayşe; Sargın, Deniz; Ünal, Ali; Turcan, Ayşegül; Beksaç, Meral (CIG Media Group, 2021)... -
The impact of donor specific anti-HLA antibodies on the outcome of allogeneic stem cell transplantation
Kekik, Çiğdem; Yönal Hindilerden, İpek; Savran Oğuz, Fatma; Usta, Sebahat; Temurhan, Sonay; Batu Demir, D.; Kalayoğlu Beşışık, Sevgi; Aktan, Melih; Sargın, Deniz (Nature Publishing Group, 2015)... -
Impact of HLA-DPB1 matching in unrelated allogeneic atem cell transplantation: Results of two centers from Turkey
Kantarcıoğlu, Bülent; Beköz, Hüseyin Saffet; Hindilerden, İpek Y.; Kıvanç, Demet; Öğret, Yeliz D.; Kalayoğlu Beşışık, Sevgi; Savran Oğuz, Fatma; Sargın, Deniz (Akad Doktorlar Yayınevi, 2017)In this study, we retrospectively examined 34 donor/recipient transplant pairs fully tested for the alleles HLA-A, B, C, DRB1, DQB1 and DPB1 in two different centers in Istanbul, Turkey. HLA-DPB1 disparity in at least one ... -
Infectious epidemiology in multiple myeloma patients after autologous stem cell transplantation: A single-center analysis from Turkey
Amikishiyev, Shirkhan; Yönal Hindilerden, İpek; Erdem, Simge; Aktan, Melih; Nalcacı, Meliha; Sargın, Deniz; Kalayoğlu Beşışık, Sevgi (Nature Publishing Group, 2018)... -
An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy
Sevindik, Ömür Gökmen; Özkurt, Zübeyde Nur; Boğa, Can; Kalayoğlu Beşışık, Sevgi; İpek, Yıldız; Gedük, Ayfer; Harmandalı, Aybüke; Salihoğlu, Ayşe; Haydaroğlu Şahin, Handan; Sönmez, Mehmet; Vural, Filiz; Akay, Olga Meltem; Kurt Yüksel, Meltem; Maral, Senem; Ekinci, Ömer; Kırkızlar, Hakkı Onur; Tekinalp, Atakan; Demir, Nazlı; Merter, Mustafa; Saydam, Güray; Alacacıoğlu, İnci; Yeğin, Zeynep Arzu; Kasar, Mutlu; Mastanzade, Metban; Özsan, Güner Hayri (CIG Media Group, 2021)Background To investigate the demographics and treatment details of the myeloma patients who were diagnosed and followed up in Turkey and received up to two lines of therapy. Methods Patients who were recorded on the ... -
An interim analysis of the Turkish myeloma registry among the patients who have received up to two lines of therapy
Sevindik, Ömür Gökmen; Özkurt, Zübeyde Nur; Boğa, Can; Kalayoğlu Beşışık, Sevgi; Yıldız, İpek; Gedük, Ayfer; Harmandali, Aybüke; Salihoğlu, Ayşe; Haydaroğlu Şahin, Handan; Sönmez, Mehmet; Vural, Filiz; Akay, Olga Meltem; Kurt Yüksel, Meltem; Maral, Senem; Ekinci, Ömer; Kırkızlar, Hakkı Onur; Tekinalp, Atakan; Demir, Nazlı; Merter, Mustafa; Saydam, Güray; Alacacıoğlu, İnci; Yeğin, Zeynep Arzu; Kaşar, Mutlu; Mastanzade, Metban; Özsan, Güner Hayri (American Society of Hematology, 2021)... -
Isatuximab in combination with lenalidomide and dexamethasone in patients with high-risk smoldering multiple myeloma: Updated safety run-in results from the randomized phase 3 ithaca study
Mateos, Maria-Victoria; Rodriguez Otero, Paula; Koh, Youngil; Martinez-Lopez, Joaquin; Parmar, Gurdeep; Prince, H. Miles; Quach, Hang; Ribas, Paz; Hermansen, Emil; Hungria, Vania T. M.; Kalayoğlu Beşışık, Sevgi; Kim, Jin Seok; Leleu, Xavier; Peceliunas, Valdas; Schjesvold, Fredrik; Sevindik, Ömür Gökmen; Lavrova, Tatiana; Dubin, Franck; Devisme, Christine; Lepine, Lucie; Ghobrial, Irene (American Society of Hematology, 2022)Background: Results from a randomized, Phase 3 study by the Spanish Myeloma Group (PETHEMA/GEM) previously showed that treatment with lenalidomide plus dexamethasone (Rd) may delay progression to active disease in patients ...
